LINNOVATEL: Lurbinectedin, Ipilimumab and Nivolumab for Soft Tissue Sarcoma
Condition:   Advanced Soft-tissue Sarcoma Intervention:   Drug: Lurbinectedin Sponsor:   ERLINDA M GORDON Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 25, 2023 Category: Research Source Type: clinical trials

LINNOVATE: Lurbinectedin, Ipilimumab and Nivolumab for Soft Tissue Sarcoma
Condition:   Advanced Soft-tissue Sarcoma Intervention:   Drug: Lurbinectedin Sponsor:   ERLINDA M GORDON Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 25, 2023 Category: Research Source Type: clinical trials